Effects of inhibition of vascular endothelial growth factor at time of selection on follicular angiogenesis, expansion, development and atresia in the marmoset.

This study determined the effects of inhibiting vascular endothelial growth factor (VEGF) at follicle selection. Marmosets were given an injection of VEGF antagonist, the VEGF Trap on Day 5 of the follicular phase and ovaries were evaluated on Day 10 or 15. Ovaries from controls were assessed on Day 5 (time of selection), Day 10 (peri-ovulatory) and Day 15 (luteal phase). At Day 10, ovaries of four of the five controls contained dominant follicles, while one had ovulated. VEGF Trap-treated ovaries also contained large follicles on Day 10, but VEGF inhibition had suppressed endothelial cell proliferation, leading to reductions in the thecal vascularization and plasma estradiol relative to controls. By Day 15, ovaries of controls contained active corpora lutea whereas ovaries of four of the five treated animals still contained large antral follicles similar in size to pre-ovulatory follicles, and one had small, avascular corpora lutea. However, these follicles had a restricted vasculature, increased incidence of activated caspase-3 staining and morphological features indicating they would become degenerative non-functional cysts. These results show that after follicle selection, VEGF is essential for angiogenesis and the generation of healthy ovulatory follicles and corpora lutea, but fluid accumulation can still occur in selected follicles in the absence of VEGF.

[1]  H. Fraser,et al.  Expression of anti-Mullerian hormone protein during early follicular development in the primate ovary in vivo is influenced by suppression of gonadotropin secretion and inhibition of vascular endothelial growth factor. , 2007, Endocrinology.

[2]  S. Wiegand,et al.  Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. , 2006, Reproduction.

[3]  S. Wiegand,et al.  Single injections of vascular endothelial growth factor trap block ovulation in the macaque and produce a prolonged, dose-related suppression of ovarian function. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  H. Fraser,et al.  Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary. , 2004, The Journal of endocrinology.

[5]  J. Petrik,et al.  Vascular endothelial growth factor and its receptor, Flk-1/KDR, are cytoprotective in the extravascular compartment of the ovarian follicle. , 2004, Endocrinology.

[6]  M. Bagheri,et al.  Ovarian stromal blood flow changes after laparoscopic ovarian cauterization in women with polycystic ovary syndrome. , 2003, Human reproduction.

[7]  C. Simón,et al.  Administration of Moderate and High Doses of Gonadotropins to Female Rats Increases Ovarian Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor-2 Expression that Is Associated to Vascular Hyperpermeability1 , 2003, Biology of reproduction.

[8]  P. Bohlen,et al.  Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. , 2003, The Journal of clinical investigation.

[9]  G. Conway,et al.  Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. , 2002, Fertility and sterility.

[10]  C. Simón,et al.  Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. , 2002, Endocrinology.

[11]  S. Harper,et al.  Regulation of vascular permeability by vascular endothelial growth factors. , 2002, Vascular pharmacology.

[12]  G. Yancopoulos,et al.  VEGF-Trap: A VEGF blocker with potent antitumor effects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Clemens,et al.  Water permeability of an ovarian antral follicle is predominantly transcellular and mediated by aquaporins. , 2002, Endocrinology.

[14]  S. Wiegand,et al.  Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. , 2002, Endocrinology.

[15]  S. Franks,et al.  Developmental origin of polycystic ovary syndrome - a hypothesis. , 2002, The Journal of endocrinology.

[16]  P. Bohlen,et al.  Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. , 2002, Endocrinology.

[17]  Y. Soong,et al.  Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. , 2002, The Journal of clinical endocrinology and metabolism.

[18]  K. Alitalo,et al.  Vascular growth factors and lymphangiogenesis. , 2002, Physiological reviews.

[19]  M. Wu,et al.  Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis. , 2002, Human reproduction.

[20]  S. Wiegand,et al.  Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). , 2001, The Journal of clinical endocrinology and metabolism.

[21]  S. Wiegand,et al.  Angiogenesis During Follicular Development in the Primate and its Inhibition by Treatment with Truncated Flt-1-Fc (Vascular Endothelial Growth Factor TrapA40). , 2001, Endocrinology.

[22]  M. Sauer,et al.  Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. , 2001, The Journal of clinical endocrinology and metabolism.

[23]  R. Gilchrist,et al.  Changes in Follicle-Stimulating Hormone and Follicle Populations During the Ovarian Cycle of the Common Marmoset1 , 2001, Biology of reproduction.

[24]  H. Fraser,et al.  The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. , 1999, Human reproduction.

[25]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[26]  R. Koos Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. , 1995, Biology of reproduction.

[27]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[28]  R. Hunter,et al.  Physiological factors underlying the formation of ovarian follicular fluid. , 1988, Journal of reproduction and fertility.

[29]  J. Hodges,et al.  Cloprostenol-induced luteolysis in the marmoset monkey (Callithrix jacchus). , 1985, Journal of reproduction and fertility.

[30]  J. Hodges,et al.  Ovulation in the marmoset monkey: endocrinology, prediction and detection. , 1984, The Journal of endocrinology.